Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: 47.48M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: August 18, 2021
Earnings History Date EPS / Forecast Revenue / Forecast August 18, 2021 June 30, 2021 - / -0.0522- / -February 9, 2021 -0.0382 / -0.0522103.04K / -Beat! November 16, 2020 -0.0784 / -0.0723- / -August 13, 2020 -0.0661 / -0.08- / 0.13Mview more
Historical Data Date Price Open High Low Vol Change ER Jul 2, 2021 0.700 0.700 0.710
0.690
102.45K 0% Jun 30, 2021 0.700 0.720 0.720
0.690
48.87K -1.41% Jun 29, 2021 0.710 0.720 0.720
0.700
25.30K -4.05% Jun 28, 2021 0.740 0.750 0.750
0.730
80.40K 0% Jun 25, 2021 0.740 0.690 0.780
0.690
146.24K 4.23% Jun 24, 2021 0.710 0.700 0.730
0.670
246.52K -1.39% Jun 23, 2021 0.720 0.830 0.830
0.700
922.02K 10.77% Jun 22, 2021 0.650 0.590 0.690
0.590
142.41K 6.56% Jun 21, 2021 0.610 0.640 0.640
0.590
68.30K -3.17% Jun 18, 2021 0.630 0.650 0.650
0.620
74.35K -3.08% view more
More profiles and info about the company News
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares finance.yahoo.com Sep 1, 2020 4:23 pm Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint marketwatch.com Sep 1, 2020 2:31 pm
Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short barrons.com Sep 1, 2020 11:07 am
Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 24, 2019: TSLA, WCC, ACST, YMAB, ITCI finance.yahoo.com Sep 1, 2020 8:13 am
Acasti Pharma Provides Fiscal 2019 Year-End Business Update finance.yahoo.com Sep 1, 2020 8:05 am
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019 finance.yahoo.com Sep 1, 2020 8:00 am
The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut finance.yahoo.com Sep 1, 2020 7:59 am
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug finance.yahoo.com Sep 1, 2020 7:55 am
Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia finance.yahoo.com Aug 31, 2020 7:00 am
Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020 finance.yahoo.com Jul 31, 2020 7:55 am
Look Anywhere but Acasti Pharma Stock for Opportunity finance.yahoo.com Jul 6, 2020 2:48 pm
Why Acasti Pharma's Stock Is Trading Higher Today finance.yahoo.com Jul 6, 2020 2:37 pm
Neptune Provides Updates on Non-Core Investments finance.yahoo.com Jul 6, 2020 1:38 pm
This Biotech Stock Is Flying High After Rival Heart Drugs Stumbled investors.com Jul 6, 2020 9:40 am Acasti Pharma files for $200M mixed shelf seekingalpha.com Jun 30, 2020 6:32 pm Acasti Pharma reports FY results seekingalpha.com Jun 29, 2020 9:54 pm Acasti Pharma under pressure on diminished expectations for second pivotal CaPre study seekingalpha.com Jun 19, 2020 8:36 pm
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package finance.yahoo.com Jun 19, 2020 8:00 am
Does The Acasti Pharma Inc. (CVE:ACST) Share Price Fall With The Market? finance.yahoo.com May 6, 2020 6:25 am
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office finance.yahoo.com Sep 1, 2020 8:00 am Talk about Acasti Pharma Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
